08 Nov, 2024
1 min read

HKG:3613 Tong Ren Tang

HKG:3613 Tong Ren Tang 1H 2022 a special dividend was announced. Final dividend got a raise of 17%. This company is heading to become dividend contender next year. And let’s not forget the beautiful dividend chart. The special dividends is left out conveniently.

1 min read

HKG:1099 SINOPHARM

HKG:1099 SINOPHARM Dividend is in RMB also here. Other than that, things look nice. Not too splendid on the yield side , but consistent growth in dividend. So sit and wait till the time is right.

1 min read

HKG:1681 Consun Pharm

HKG:1681 Consun Pharm The pharmaceutical products of the Company include kidney medicines, contrast medium and others. The Company’s subsidiaries include Brilliant Reach Group Limited, Century International Develop Limited and Grand Reach Company Limited. Through its subsidiaries, the Company is also engaged in the research and development of pharmaceutical products.

1 min read

HKG:1177 Sino Biopharm

HKG:1177 Sino Biopharm The Group’s business works in a fully integrated chain which spans from R&D to manufacture and sales of pharmaceutical products, covering a vast array of biopharmaceutical, chemical and modernized Chinese medicines. Interim result 2022 are favorable for dividends (+200%) yet EPS fell 77%

1 min read

HKG:0867 CMS

HKG:0867 CMS What a beautiful chart! Results of 2022 are okay. Dividends got up 2.5% , Debt/Equity remained stable.  This looks promising  in terms of higher proceeds of holding this stock. (Average 5-yr Dividend Growth is almost 15%)